000 01543 a2200445 4500
005 20250512010452.0
264 0 _c19900122
008 199001s 0 0 eng d
022 _a0277-5379
024 7 _a10.1016/0277-5379(89)90299-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLennard, T W
245 0 0 _aA phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738).
_h[electronic resource]
260 _bEuropean journal of cancer & clinical oncology
_cNov 1989
300 _a1571-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcridines
_xadverse effects
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdjuvants, Immunologic
_xadverse effects
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
700 1 _aHarris, A L
700 1 _aHales, J
700 1 _aDickinson, A
700 1 _aWolstencroft, R
700 1 _aHalcrow, P
700 1 _aShenton, B K
700 1 _aMcDonald, M
700 1 _aLawrence, G F
700 1 _aTaylor, R M
773 0 _tEuropean journal of cancer & clinical oncology
_gvol. 25
_gno. 11
_gp. 1571-6
856 4 0 _uhttps://doi.org/10.1016/0277-5379(89)90299-x
_zAvailable from publisher's website
999 _c2597347
_d2597347